Microbiome may hold key to identifying HPV-infected women at risk for pre-cancer
Gardnerella bacteria in the cervicovaginal microbiome may serve as a biomarker to identify women infected with…
Browsing: Gynaecologic Cancers
New research shows which ovarian cancer patients won’t benefit from immune-PARP combo
In patients with advanced ovarian cancer, a combination of drugs known as immune checkpoint inhibitors…
Therapeutic HPV vaccine may improve outcomes in advanced cervical cancer
Combining a therapeutic vaccine for human papilloma virus (HPV) with two standard chemotherapy drugs may…
Immunosuppressive therapy for inflammatory bowel disease does not increase women’s risk of vulvar or vaginal cancer
In a retrospective study, researchers found that the use of immunosuppressive therapy does not increase…
Study evaluates cervical cancer risks of IUDs
Patients who used copper intrauterine devices (Cu IUD) were found to have a lower risk…
A simple way to promote HPV vaccination among Asian American women: Storytelling
Minjin Kim, University of Massachusetts Medical School Asian Americans and Pacific Islanders – what demographers…
Risk factors for endometrial cancer
An analysis of 149 scientific studies has identified 24 genetic variants which predispose women to…
Combined therapy may improve clinical responses for endometrial, colorectal and gastric tumours
A study at The University of Texas MD Anderson Cancer Center, USA, discovered a novel…
Test measures immune response to improve ovarian cancer diagnosis
Researchers have developed a simple blood test that measures the body’s own immune response to…
Cervical cancer elimination possible within two decades in the US
Scaling up cervical cancer screening coverage in the U.S. to 90% could expedite elimination of…